| IPAD-DB ID | C00052 |
| Name | LY3202626 |
| Category | Natural compounds |
| 2D Structure |
|
| 3D Structure | |
| Molecular Formula | C 2 2 H 2 0 F 2 N 8 O 2 S |
| Molecular Weight | 498.5 g/mol |
| IUPAC Name | N-[3-[(4aR, 7aS)-2-amino-6-(5-fluoropyrimidin-2-yl)-4, 4a, 5, 7-tetrahydropyrrolo[3, 4-d][1, 3]thiazin-7a-yl]-4-fluorophenyl]-5-methoxypyrazine-2-carboxamide |
| InChI | InChI=1S/C22H20F2N8O2S/c1-34-18-8-26-17(7-27-18)19(33)30-14-2-3-16(24)15(4-14)22-11-32(21-28-5-13(23)6-29-21)9-12(22)10-35-20(25)31-22/h2-8, 12H, 9-11H2, 1H3, (H2, 25, 31)(H, 30, 33)/t12-, 22-/m0/s1 |
| InChIKey | VQSRKMNBWMHJKY-YTEVENLXSA-N |
| Canonical SMILES | COC1=NC=C(N=C1)C(=O)NC2=CC(=C(C=C2)F)C34CN(CC3CSC(=N4)N)C5=NC=C(C=N5)F |
| PubChem CID | 78210254 |
| DrugBank Accession Number | - |
| CAS Registry Number | 1628690-73-2 |
| Molecular Weight(Computed by SwissADME) | 498.51 |
| Hac(Computed by SwissADME) | 35 |
| Volume(Computed by ADMETlab 2.0) | 453.483 |
| Density(Computed by ADMETlab 2.0) | 1.098 |
| nRing(Computed by ADMETlab 2.0) | 5 |
| MaxRing(Computed by ADMETlab 2.0) | 9 |
| nHet(Computed by ADMETlab 2.0) | 13 |
| fChar(Computed by ADMETlab 2.0) | 0 |
| nRig(Computed by ADMETlab 2.0) | 30 |
| Flexibility(Computed by ADMETlab 2.0) | 0.2 |
| Stero Centers(Computed by ADMETlab 2.0) | 2 |
| LogS(Computed by ADMETlab 2.0) | -3.894 |
| LogD(Computed by ADMETlab 2.0) | 2.929 |
| logP(Computed by ADMETlab 2.0) | 2.83 |
| TPSA(Computed by SwissADME) | 156.81 |
| Hbond Acceptor(Computed by SwissADME) | 9 |
| Hbond Donor(Computed by SwissADME) | 2 |
| Rotatable Bonds(Computed by SwissADME) | 6 |
| GI Absorption(Computed by SwissADME) | Low |
| BBB(blood-brain barrier) Permeant(Computed by SwissADME) | No |
| P-gp Substrate(Computed by SwissADME) | Yes |
| CYP1A2 Inhibitor(Computed by SwissADME) | No |
| CYP2C19 Inhibitor(Computed by SwissADME) | No |
| CYP2C9 Inhibitor(Computed by SwissADME) | No |
| CYP2D6 Inhibitor(Computed by SwissADME) | No |
| CYP3A4 Inhibitor(Computed by SwissADME) | Yes |
| log Kp(Skin Permeation)(Computed by SwissADME) | -8.43 |
| Lipinski(Computed by SwissADME) | 0 |
| Ghose(Computed by SwissADME) | 2 |
| Veber(Computed by SwissADME) | 1 |
| Egan(Computed by SwissADME) | 1 |
| Muegge(Computed by SwissADME) | 1 |
| Bioavailability Score(Computed by SwissADME) | 0.55 |